Chen Guanzhong, Yan Xiaoming, Huang Zhidong, Liu Liwei, Meng Liangguang, Li Min, Liu Jin, Chen Shiqun, Li Huanqiang, Mai Ziling, Chen Enzhao, Lai Disheng, Wang Bo, Huang Haozhang, Tan Ning, Liu Yong, Wei Shuisheng, Chen Jiyan
Guangdong Provincial People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ann Transl Med. 2020 Oct;8(19):1241. doi: 10.21037/atm-20-6365.
Dialysis-requiring acute kidney injury (AKI-D) is a potentially serious complication associated with high in-hospital mortality among patients with coronary artery disease (CAD) after coronary angiography (CAG). Patients with existing advanced kidney disease (AKD) have an increased risk of developing AKI-D. However, few studies have investigated the prognosis of AKI-D in patients with both CAD and AKD.
In this observational study, 603 CAD patients with AKD (estimated glomerular filtration rate, eGFR <30 mL/min/1.73 m) were enrolled. AKI-D was defined as acute or worsening renal failure requiring the initiation of renal dialysis. The primary endpoint was 90-day all-cause mortality. Kaplan-Meier and Cox regression analyses were used to assess the association of AKI-D and 90-day all-cause mortality among CAD patients complicated with AKD.
Overall, among 603 CAD patients complicated with AKD, 83 patients (13.8%) required AKI-D. Patients underwent AKI-D had a significantly higher rate of 90-day mortality than those who did not (13.3% . 6.5%, log rank P=0.028), with an unadjusted hazard ratio (HR) of 1.28 [95% confidence interval (CI): 1.02-1.61, P=0.032]. After adjustment for cardiac and renal impairment, however, AKI-D was no longer associated with 90-day mortality (HR: 1.08, 95% CI: 0.84-1.39, P=0.559). The attenuation analysis showed that after adjustment for cardiac and renal function, the residual effect of 90-day mortality was as low as 30% of the unadjusted effect.
The incidence of AKI-D is high among patients with CAD complicated by AKD. The high 90-day mortality rate of patients undergoing AKI-D is mainly attributable to cardio-renal impairment.
需要透析的急性肾损伤(AKI-D)是冠状动脉造影(CAG)后冠心病(CAD)患者潜在的严重并发症,与高院内死亡率相关。已有晚期肾病(AKD)的患者发生AKI-D的风险增加。然而,很少有研究调查同时患有CAD和AKD的患者中AKI-D的预后情况。
在这项观察性研究中,纳入了603例患有AKD(估计肾小球滤过率,eGFR<30 mL/min/1.73 m²)的CAD患者。AKI-D被定义为需要开始肾脏透析的急性或恶化性肾衰竭。主要终点是90天全因死亡率。采用Kaplan-Meier和Cox回归分析来评估AKI-D与合并AKD的CAD患者90天全因死亡率之间的关联。
总体而言,在603例合并AKD的CAD患者中,83例(13.8%)需要AKI-D。接受AKI-D的患者90天死亡率显著高于未接受者(13.3%对6.5%,对数秩检验P=0.028),未调整的风险比(HR)为1.28[95%置信区间(CI):1.02-1.61,P=0.032]。然而,在调整了心脏和肾脏损害因素后,AKI-D与90天死亡率不再相关(HR:1.08,95%CI:0.84-1.39,P=0.559)。衰减分析表明,在调整心脏和肾脏功能后,90天死亡率的残余效应低至未调整效应的30%。
合并AKD的CAD患者中AKI-D的发生率较高。接受AKI-D的患者90天死亡率高主要归因于心肾损害。